Extracellular volume expansion in peritoneal dialysis patients

International Journal of Artificial Organs

Volumn 35, Issue 5, 2012, Pages 338-345

  Fan, Stanley ^a   Sayed, Rabya H ^a   Davenport, Andrew ^b  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Albumin; Bio impedance; C reactive protein; Icodextrin; Peritoneal dialysis; Residual renal function

Indexed keywords

BODY FLUIDS; DIALYSIS; MULTIVARIANT ANALYSIS; PROTEINS;

ALBUMIN; BIO-IMPEDANCE; C-REACTIVE PROTEINS; EXTRACELLULAR; EXTRACELLULAR VOLUMES; ICODEXTRIN; PERITONEAL DIALYSIS; RENAL FUNCTIONS; RESIDUAL RENAL FUNCTION; VOLUME EXPANSION;

PATHOLOGY;

ALBUMIN; ANTIHYPERTENSIVE AGENT; GLUCOSE; ICODEXTRIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CAUCASIAN; CELLULAR PARAMETERS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIALYSATE; EXTRACELLULAR FLUID; EXTRACELLULAR VOLUME EXPANSION; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; RESIDUAL RENAL FUNCTION; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; TOTAL BODY WATER; URINE VOLUME;

EID: 84863195698     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000080     Document Type: Article

References (31)

1. Davenport A. Intradialytic complications during hemodialysis. Hemodial Int. 2006;10(2):162-167. Medline. doi:10.1111/ j.1542-4758.2006.00088.x
2. Davenport A, Cox C, Thuraisingham R. Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension. Kidney Int. 2008;73(6):759-764. Medline. doi:10.1038/sj.ki.5002745
3. Jager KJ, Merkus MP, Dekker FW, et al. Mortality and technique failure in patients starting chronic PD: results of The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int. 1999;55(4):1476-1485. Medline. doi:10.1046/j.1523-1755.1999.00353.x
4. Wang AY, Lam CW, Yu CM, et al. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic PD patients. J Am Soc Nephrol. 2007;18(1):321-330. Medline. doi:10.1681/ASN.2005121299
5. Booth J, Pinney J, Davenport A. N-terminal proBNP--marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients? Clin J Am Soc Nephrol. 2010;5(6):1036-1040. Medline. doi:10.2215/CJN.09001209
6. Papakrivopoulou E, Lillywhite S, Davenport A. Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in PD patients? Nephrol Dial Transplant.2012 Jan;27(1):396-401
7. Michels WM, Verduijn M, Boeschoten EW, Dekker FW, Krediet RT; NECOSAD Study Group. Similar survival on automated PD and continuous ambulatory PD in a large prospective cohort. Clin J Am Soc Nephrol. 2009;4(5):943-949. Medline. doi:10.2215/CJN.04440908
8. Chen W, Guo LJ, Wang T. ECW /intracellular water is a strong predictor of patient survival in incident PD patients. Blood Purif. 2007;25(3):260-266. Medline. doi:10.1159/000101699
9. Davenport A. Peritonitis remains the major clinical complication of PD: the London, UK, peritonitis audit 2002-2003. Perit Dial Int. 2009;29(3):297-302.
10. Balasubramaniam G, Brown EA, Davenport A, et al. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2009;24(10):3209-3215. Medline. doi:10.1093/ndt/gfp008
11. Habib AM, Preston E, Davenport A. Risk factors for developing encapsulating peritoneal sclerosis in the icodextrin era of PD prescription. Nephrol Dial Transplant. 2010;25(5):1633-1638. Medline. doi:10.1093/ndt/gfp677
12. Davenport A, Willicombe M. Comparison of fluid status in patients treated by different modalities of PD using multi-frequency bioimpedance. Int J Artif Organs. 2009;32(11):779-786.
13. Davenport A, Willicombe MK. Hydration status does not influence peritoneal equilibration test ultrafiltration volumes. Clin J Am Soc Nephrol. 2009;4(7):1207-1212. Medline. doi:10.2215/CJN.01060209
14. Keshaviah PR, Nolph KD, Prowant B, et al. Defining adequacy of CAPD with urea kinetics. Adv Perit Dial. 1990;6:173-177.
15. Twardowski ZJ. PET--a simpler approach for determining prescriptions for adequate dialysis therapy. Adv Perit Dial. 1990;6:186-191.
16. Konings CJ, Kooman JP, Schonck M, et al. Assessment of fluid status in PD patients. Perit Dial Int. 2002;22(6):683-692.
17. Woodrow G. ECW expansion: part of the malnutritioninflammation-atherosclerosis syndrome? Perit Dial Int. 2006;26(5):566-570.
18. Woodrow G, Devine Y, Cullen M, Lindley E. Application of bioelectrical impedance to clinical assessment of body composition in PD. Perit Dial Int. 2007;27(5):496-502.
19. Bargman JM, Thorpe KE, Churchill DN; CANUSA PD Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001;12(10):2158-2162.
20. Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT; NECOSAD Study Group. The relative importance of residual renal function compared with peritoneal clearance for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis. 2003;41(6):1293-1302. Medline. doi:10.1016/S0272-6386(03)00362-7
21. Konings CJ, Kooman JP, Schonck M, et al. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. Nephrol Dial Transplant. 2003;18(4):797-803. Medline. doi:10.1093/ ndt/gfg147
22. Wang T, Heimbürger O, Waniewski J, Bergström J, Lindholm B. Increased peritoneal permeability is associated with decreased fluid and small-solute removal and higher mortality in CAPD patients. Nephrol Dial Transplant. 1998;13(5):1242-1249. Medline. doi:10.1093/ndt/13.5.1242
23. Davies SJ, Woodrow G, Donovan K, et al. Icodextrin improves the fluid status of PD patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol. 2003;14(9):2338-2344. Medline. doi:10.1097/01.ASN.0000083904.12234.27
24. Davenport A, Willicombe MK. Does diabetes mellitus predispose to increased fluid overload in PD patients? Nephron Clin Pract. 2010;114(1):c60-c66. Medline. doi:10.1159/000245070
25. Davenport A. Interdialytic weight gain in diabetic hemodialysis patients and diabetic control as assessed by glycated hemoglobin. Nephron Clin Pract. 2009;113(1):c33-c37. Medline. doi:10.1159/000228073
26. Fürstenberg A, Davenport A. Comparison of multifrequency bioelectrical impedance analysis and dual-energy X-ray absorptiometry assessments in outpatient hemodialysis patients. Am J Kidney Dis. 2011;57(1):123-129. Medline. doi:10.1053/j.ajkd.2010.05.022
27. Jones CH, Wells L, Stoves J, Farquhar F, Woodrow G. Can a reduction in extracellular fluid volume result in increased serum albumin in PD patients? Am J Kidney Dis. 2002;39(4):872-875. Medline. doi:10.1053/ajkd.2002.32010
28. Woodrow G, Oldroyd B, Wright A, Coward WA, Truscott JG. The effect of normalization of ECW volume as a marker of hydration in PD patients and controls. Perit Dial Int. 2005;25(Suppl 3):S49-S51.
29. Van der Kerkhof J, Hermans M, Beerenhout C, Konings C, Van der Sande FM, Kooman JP. Reference values for multifrequency bioimpedance analysis in dialy sis patients. Blood Purif. 2004;22(3):301-306. Medline. doi:10.1159/000078761
30. Davies SJ, Garcia Lopez E, Woodrow G, et al. Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin. Nephrol Dial Transplant. 2008;23(9):2982-2988. Medline. doi:10.1093/ ndt/gfn176
31. John B, Tan BK, Dainty S, Spanel P, Smith D, Davies SJ. Plasma volume, albumin, and fluid status in PD patients. Clin J Am Soc Nephrol. 2010;5(8):1463-1470. Medline. doi:10.2215/CJN.09411209